Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacological modulation of plaque instability.

A Mezzetti1

  • 1Atherosclerosis Prevention Center, G d'Annunzio University of Chieti, Chieti, Italy. mezzetti@unich.it

Lupus
|October 13, 2005
PubMed
Summary

Simvastatin and irbesartan stabilize atherosclerotic plaques by reducing inflammation and suppressing prostaglandin E2-dependent metalloproteinase release, mitigating plaque rupture risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of microRNAs 758 and 33b as potential modulators of ABCA1 expression in human atherosclerotic plaques.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Same author

Care manager to control cardiovascular risk factors in primary care: the Raffaello cluster randomized trial.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Same author

Pitfalls of contrast-enhanced ultrasound (CEUS) in the diagnosis of splenic sarcoidosis.

Journal of ultrasound·2013
Same author

Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial.

International journal of nursing studies·2013
Same author

Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: a population-based cohort study in Italy.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2013
Same author

Immunopathogenesis of sarcoidosis and risk of malignancy: a lost truth?

International journal of immunopathology and pharmacology·2013

Area of Science:

  • Cardiovascular Research
  • Inflammation and Immunology

Background:

  • Atherosclerotic plaque rupture, driven by matrix metalloproteinases (MMPs), is a critical event in cardiovascular disease.
  • Prostaglandin E2 (PGE2), synthesized via cyclooxygenase-2 (COX-2)/microsomal prostaglandin E synthase-1 (mPGES-1), promotes MMP biosynthesis and plaque instability.
  • Overexpression of COX-2/mPGES-1 is observed in vulnerable atherosclerotic plaques.

Purpose of the Study:

  • To investigate the potential of simvastatin and irbesartan to stabilize atherosclerotic plaques.
  • To determine if these drugs modulate the COX-2/mPGES-1 pathway and subsequent MMP biosynthesis.

Main Methods:

  • Evaluation of the effects of simvastatin and irbesartan on atherosclerotic plaque stability in preclinical models.
  • Assessment of changes in inflammatory markers and PGE2-dependent MMP release following drug treatment.

Main Results:

  • Simvastatin and irbesartan demonstrated a plaque-stabilizing effect.
  • These drugs reduced the inflammatory burden within plaques.
  • Treatment suppressed the release of PGE2-dependent metalloproteinases.

Conclusions:

  • Simvastatin and irbesartan can stabilize atherosclerotic plaques, partly by reducing inflammation.
  • Modulation of the COX-2/mPGES-1 pathway and subsequent MMP release contributes to the therapeutic benefits of these drugs in atherosclerosis.

Related Experiment Videos